The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CARIBOU BIOSCIENCES INC | COM | 142038108 | 6,189 | 674,196 | SH | SOLE | 674,196 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 2,406 | 6,887 | SH | SOLE | 6,887 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 3,216 | 602,272 | SH | SOLE | 602,272 | 0 | 0 | ||
ROYALTY PHARMA PLC | SHS CL A | G7709Q104 | 43,957 | 1,128,255 | SH | SOLE | 1,128,255 | 0 | 0 | ||
VANECK ETF TRUST | GOLD MINERS ETF | 92189F106 | 28,321 | 738,500 | SH | SOLE | 738,500 | 0 | 0 | ||
Y-MABS THERAPEUTICS INC | COM | 984241109 | 2,271 | 191,176 | SH | SOLE | 191,176 | 0 | 0 |